Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2023-2025 National HTA Program for Medical Devices adopted in Italy

On September 5, 2023, the Ministry of Health published the Decree of June 9, 2023, on the adoption of the 2023-2025 National HTA Medical Devices Program.

The plan was prepared by the National Agency for Regional Health Services (AGENAS) and approved by the program’s Steering Committee (Cabina di Regia) and the State-Regions Conference. 

Although the Program was established in 2017, it will become fully functional only in Q3 of 2023, with the first assessment being initiated in early 2024. This will have an impact on the adoption of healthcare technologies by healthcare providers throughout the country.

The Program is expected to be updated every three years.

See the details in Italian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.